Pharma & Healthcare
Global Oral Retinoids Market Research Report 2026
- Feb 03, 26
- ID: 699594
- Pages: 139
- Figures: 147
- Views: 8
This report delivers a comprehensive overview of the global Oral Retinoids market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Retinoids. The Oral Retinoids market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oral Retinoids market comprehensively. Regional market sizes by Type, by Application, by Strength, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Retinoids manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Galderma Laboratories
Bausch Health
Actavis
Stiefel Laboratories
GlaxoSmithKline
Dr. Reddy's Laboratories
Barr Pharmaceuticals
Impax Laboratories
Mylan
Teva
Alembic
Sigmapharm Laboratories
Amneal Pharmaceuticals
Upsher-Smith
Zydus
Par Pharmaceutical
Fuji Pharma
Shandong Liangfu Pharmaceutical
Chongqing Huapont Pharmaceutical
Harbin Dazhong Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Heilongjiang Fuhe Pharmaceutical
HEC Pharm
Segment by Type
Tretinoin
Isotretinoin
Acitretin
Bexarotene
Alitretinoin
Segment by Strength
Low Strength
Medium Strength
High Strength
Segment by Packaging
Bottle Pack
Blister Pack
by Application
Hospital and Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Strength, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Oral Retinoids manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Oral Retinoids sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Oral Retinoids market comprehensively. Regional market sizes by Type, by Application, by Strength, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Retinoids manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Galderma Laboratories
Bausch Health
Actavis
Stiefel Laboratories
GlaxoSmithKline
Dr. Reddy's Laboratories
Barr Pharmaceuticals
Impax Laboratories
Mylan
Teva
Alembic
Sigmapharm Laboratories
Amneal Pharmaceuticals
Upsher-Smith
Zydus
Par Pharmaceutical
Fuji Pharma
Shandong Liangfu Pharmaceutical
Chongqing Huapont Pharmaceutical
Harbin Dazhong Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Heilongjiang Fuhe Pharmaceutical
HEC Pharm
Segment by Type
Tretinoin
Isotretinoin
Acitretin
Bexarotene
Alitretinoin
Segment by Strength
Low Strength
Medium Strength
High Strength
Segment by Packaging
Bottle Pack
Blister Pack
by Application
Hospital and Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Strength, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Oral Retinoids manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Oral Retinoids sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Oral Retinoids Market Overview
1.1 Product Definition
1.2 Oral Retinoids by Type
1.2.1 Global Oral Retinoids Market Value by Type: 2025 vs 2032
1.2.2 Tretinoin
1.2.3 Isotretinoin
1.2.4 Acitretin
1.2.5 Bexarotene
1.2.6 Alitretinoin
1.3 Oral Retinoids by Strength
1.3.1 Global Oral Retinoids Market Value by Strength: 2025 vs 2032
1.3.2 Low Strength
1.3.3 Medium Strength
1.3.4 High Strength
1.4 Oral Retinoids by Packaging
1.4.1 Global Oral Retinoids Market Value by Packaging: 2025 vs 2032
1.4.2 Bottle Pack
1.4.3 Blister Pack
1.5 Oral Retinoids by Application
1.5.1 Global Oral Retinoids Market Value by Application: 2025 vs 2032
1.5.2 Hospital and Clinic
1.5.3 Pharmacy
1.5.4 Other
1.6 Global Oral Retinoids Market Size Estimates and Forecasts
1.6.1 Global Oral Retinoids Revenue 2021–2032
1.6.2 Global Oral Retinoids Sales 2021–2032
1.6.3 Global Oral Retinoids Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Oral Retinoids Market Competition by Manufacturers
2.1 Global Oral Retinoids Sales Market Share by Manufacturers (2021–2026)
2.2 Global Oral Retinoids Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Oral Retinoids Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Oral Retinoids, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Oral Retinoids, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Oral Retinoids, Product Types and Applications
2.7 Global Key Manufacturers of Oral Retinoids, Date of Entry into the Industry
2.8 Global Oral Retinoids Market Competitive Situation and Trends
2.8.1 Global Oral Retinoids Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Oral Retinoids Players Market Share by Revenue
2.8.3 Global Oral Retinoids Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Retinoids Market Scenario by Region
3.1 Global Oral Retinoids Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Oral Retinoids Sales by Region: 2021–2032
3.2.1 Global Oral Retinoids Sales by Region: 2021–2026
3.2.2 Global Oral Retinoids Sales by Region: 2027–2032
3.3 Global Oral Retinoids Revenue by Region: 2021–2032
3.3.1 Global Oral Retinoids Revenue by Region: 2021–2026
3.3.2 Global Oral Retinoids Revenue by Region: 2027–2032
3.4 North America Oral Retinoids Market Facts & Figures by Country
3.4.1 North America Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Oral Retinoids Sales by Country (2021–2032)
3.4.3 North America Oral Retinoids Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Retinoids Market Facts & Figures by Country
3.5.1 Europe Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Oral Retinoids Sales by Country (2021–2032)
3.5.3 Europe Oral Retinoids Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Retinoids Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Retinoids Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Oral Retinoids Sales by Region (2021–2032)
3.6.3 Asia Pacific Oral Retinoids Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Retinoids Market Facts & Figures by Country
3.7.1 Latin America Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Oral Retinoids Sales by Country (2021–2032)
3.7.3 Latin America Oral Retinoids Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Retinoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Oral Retinoids Sales by Country (2021–2032)
3.8.3 Middle East and Africa Oral Retinoids Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Retinoids Sales by Type (2021–2032)
4.1.1 Global Oral Retinoids Sales by Type (2021–2026)
4.1.2 Global Oral Retinoids Sales by Type (2027–2032)
4.1.3 Global Oral Retinoids Sales Market Share by Type (2021–2032)
4.2 Global Oral Retinoids Revenue by Type (2021–2032)
4.2.1 Global Oral Retinoids Revenue by Type (2021–2026)
4.2.2 Global Oral Retinoids Revenue by Type (2027–2032)
4.2.3 Global Oral Retinoids Revenue Market Share by Type (2021–2032)
4.3 Global Oral Retinoids Price by Type (2021–2032)
5 Segment by Application
5.1 Global Oral Retinoids Sales by Application (2021–2032)
5.1.1 Global Oral Retinoids Sales by Application (2021–2026)
5.1.2 Global Oral Retinoids Sales by Application (2027–2032)
5.1.3 Global Oral Retinoids Sales Market Share by Application (2021–2032)
5.2 Global Oral Retinoids Revenue by Application (2021–2032)
5.2.1 Global Oral Retinoids Revenue by Application (2021–2026)
5.2.2 Global Oral Retinoids Revenue by Application (2027–2032)
5.2.3 Global Oral Retinoids Revenue Market Share by Application (2021–2032)
5.3 Global Oral Retinoids Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Galderma Laboratories
6.1.1 Galderma Laboratories Company Information
6.1.2 Galderma Laboratories Description and Business Overview
6.1.3 Galderma Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Galderma Laboratories Oral Retinoids Product Portfolio
6.1.5 Galderma Laboratories Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Company Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bausch Health Oral Retinoids Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Company Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Actavis Oral Retinoids Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Stiefel Laboratories
6.4.1 Stiefel Laboratories Company Information
6.4.2 Stiefel Laboratories Description and Business Overview
6.4.3 Stiefel Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stiefel Laboratories Oral Retinoids Product Portfolio
6.4.5 Stiefel Laboratories Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 GlaxoSmithKline Oral Retinoids Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Company Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 Barr Pharmaceuticals
6.7.1 Barr Pharmaceuticals Company Information
6.7.2 Barr Pharmaceuticals Description and Business Overview
6.7.3 Barr Pharmaceuticals Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
6.7.5 Barr Pharmaceuticals Recent Developments/Updates
6.8 Impax Laboratories
6.8.1 Impax Laboratories Company Information
6.8.2 Impax Laboratories Description and Business Overview
6.8.3 Impax Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Impax Laboratories Oral Retinoids Product Portfolio
6.8.5 Impax Laboratories Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Oral Retinoids Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Teva
6.10.1 Teva Company Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teva Oral Retinoids Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Alembic
6.11.1 Alembic Company Information
6.11.2 Alembic Description and Business Overview
6.11.3 Alembic Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Alembic Oral Retinoids Product Portfolio
6.11.5 Alembic Recent Developments/Updates
6.12 Sigmapharm Laboratories
6.12.1 Sigmapharm Laboratories Company Information
6.12.2 Sigmapharm Laboratories Description and Business Overview
6.12.3 Sigmapharm Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
6.12.5 Sigmapharm Laboratories Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Upsher-Smith
6.14.1 Upsher-Smith Company Information
6.14.2 Upsher-Smith Description and Business Overview
6.14.3 Upsher-Smith Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Upsher-Smith Oral Retinoids Product Portfolio
6.14.5 Upsher-Smith Recent Developments/Updates
6.15 Zydus
6.15.1 Zydus Company Information
6.15.2 Zydus Description and Business Overview
6.15.3 Zydus Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zydus Oral Retinoids Product Portfolio
6.15.5 Zydus Recent Developments/Updates
6.16 Par Pharmaceutical
6.16.1 Par Pharmaceutical Company Information
6.16.2 Par Pharmaceutical Description and Business Overview
6.16.3 Par Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Par Pharmaceutical Oral Retinoids Product Portfolio
6.16.5 Par Pharmaceutical Recent Developments/Updates
6.17 Fuji Pharma
6.17.1 Fuji Pharma Company Information
6.17.2 Fuji Pharma Description and Business Overview
6.17.3 Fuji Pharma Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Fuji Pharma Oral Retinoids Product Portfolio
6.17.5 Fuji Pharma Recent Developments/Updates
6.18 Shandong Liangfu Pharmaceutical
6.18.1 Shandong Liangfu Pharmaceutical Company Information
6.18.2 Shandong Liangfu Pharmaceutical Description and Business Overview
6.18.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
6.18.5 Shandong Liangfu Pharmaceutical Recent Developments/Updates
6.19 Chongqing Huapont Pharmaceutical
6.19.1 Chongqing Huapont Pharmaceutical Company Information
6.19.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.19.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
6.19.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.20 Harbin Dazhong Pharmaceutical
6.20.1 Harbin Dazhong Pharmaceutical Company Information
6.20.2 Harbin Dazhong Pharmaceutical Description and Business Overview
6.20.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
6.20.5 Harbin Dazhong Pharmaceutical Recent Developments/Updates
6.21 Sichuan Med-Shine Pharmaceutical
6.21.1 Sichuan Med-Shine Pharmaceutical Company Information
6.21.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.21.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
6.21.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.22 Heilongjiang Fuhe Pharmaceutical
6.22.1 Heilongjiang Fuhe Pharmaceutical Company Information
6.22.2 Heilongjiang Fuhe Pharmaceutical Description and Business Overview
6.22.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
6.22.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
6.23 HEC Pharm
6.23.1 HEC Pharm Company Information
6.23.2 HEC Pharm Description and Business Overview
6.23.3 HEC Pharm Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 HEC Pharm Oral Retinoids Product Portfolio
6.23.5 HEC Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Retinoids Industry Chain Analysis
7.2 Oral Retinoids Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Retinoids Production Mode & Process Analysis
7.4 Oral Retinoids Sales and Marketing
7.4.1 Oral Retinoids Sales Channels
7.4.2 Oral Retinoids Distributors
7.5 Oral Retinoids Customer Analysis
8 Oral Retinoids Market Dynamics
8.1 Oral Retinoids Industry Trends
8.2 Oral Retinoids Market Drivers
8.3 Oral Retinoids Market Challenges
8.4 Oral Retinoids Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Oral Retinoids by Type
1.2.1 Global Oral Retinoids Market Value by Type: 2025 vs 2032
1.2.2 Tretinoin
1.2.3 Isotretinoin
1.2.4 Acitretin
1.2.5 Bexarotene
1.2.6 Alitretinoin
1.3 Oral Retinoids by Strength
1.3.1 Global Oral Retinoids Market Value by Strength: 2025 vs 2032
1.3.2 Low Strength
1.3.3 Medium Strength
1.3.4 High Strength
1.4 Oral Retinoids by Packaging
1.4.1 Global Oral Retinoids Market Value by Packaging: 2025 vs 2032
1.4.2 Bottle Pack
1.4.3 Blister Pack
1.5 Oral Retinoids by Application
1.5.1 Global Oral Retinoids Market Value by Application: 2025 vs 2032
1.5.2 Hospital and Clinic
1.5.3 Pharmacy
1.5.4 Other
1.6 Global Oral Retinoids Market Size Estimates and Forecasts
1.6.1 Global Oral Retinoids Revenue 2021–2032
1.6.2 Global Oral Retinoids Sales 2021–2032
1.6.3 Global Oral Retinoids Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Oral Retinoids Market Competition by Manufacturers
2.1 Global Oral Retinoids Sales Market Share by Manufacturers (2021–2026)
2.2 Global Oral Retinoids Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Oral Retinoids Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Oral Retinoids, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Oral Retinoids, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Oral Retinoids, Product Types and Applications
2.7 Global Key Manufacturers of Oral Retinoids, Date of Entry into the Industry
2.8 Global Oral Retinoids Market Competitive Situation and Trends
2.8.1 Global Oral Retinoids Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Oral Retinoids Players Market Share by Revenue
2.8.3 Global Oral Retinoids Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Retinoids Market Scenario by Region
3.1 Global Oral Retinoids Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Oral Retinoids Sales by Region: 2021–2032
3.2.1 Global Oral Retinoids Sales by Region: 2021–2026
3.2.2 Global Oral Retinoids Sales by Region: 2027–2032
3.3 Global Oral Retinoids Revenue by Region: 2021–2032
3.3.1 Global Oral Retinoids Revenue by Region: 2021–2026
3.3.2 Global Oral Retinoids Revenue by Region: 2027–2032
3.4 North America Oral Retinoids Market Facts & Figures by Country
3.4.1 North America Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Oral Retinoids Sales by Country (2021–2032)
3.4.3 North America Oral Retinoids Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Retinoids Market Facts & Figures by Country
3.5.1 Europe Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Oral Retinoids Sales by Country (2021–2032)
3.5.3 Europe Oral Retinoids Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Retinoids Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Retinoids Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Oral Retinoids Sales by Region (2021–2032)
3.6.3 Asia Pacific Oral Retinoids Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Retinoids Market Facts & Figures by Country
3.7.1 Latin America Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Oral Retinoids Sales by Country (2021–2032)
3.7.3 Latin America Oral Retinoids Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Retinoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Retinoids Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Oral Retinoids Sales by Country (2021–2032)
3.8.3 Middle East and Africa Oral Retinoids Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Retinoids Sales by Type (2021–2032)
4.1.1 Global Oral Retinoids Sales by Type (2021–2026)
4.1.2 Global Oral Retinoids Sales by Type (2027–2032)
4.1.3 Global Oral Retinoids Sales Market Share by Type (2021–2032)
4.2 Global Oral Retinoids Revenue by Type (2021–2032)
4.2.1 Global Oral Retinoids Revenue by Type (2021–2026)
4.2.2 Global Oral Retinoids Revenue by Type (2027–2032)
4.2.3 Global Oral Retinoids Revenue Market Share by Type (2021–2032)
4.3 Global Oral Retinoids Price by Type (2021–2032)
5 Segment by Application
5.1 Global Oral Retinoids Sales by Application (2021–2032)
5.1.1 Global Oral Retinoids Sales by Application (2021–2026)
5.1.2 Global Oral Retinoids Sales by Application (2027–2032)
5.1.3 Global Oral Retinoids Sales Market Share by Application (2021–2032)
5.2 Global Oral Retinoids Revenue by Application (2021–2032)
5.2.1 Global Oral Retinoids Revenue by Application (2021–2026)
5.2.2 Global Oral Retinoids Revenue by Application (2027–2032)
5.2.3 Global Oral Retinoids Revenue Market Share by Application (2021–2032)
5.3 Global Oral Retinoids Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Galderma Laboratories
6.1.1 Galderma Laboratories Company Information
6.1.2 Galderma Laboratories Description and Business Overview
6.1.3 Galderma Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Galderma Laboratories Oral Retinoids Product Portfolio
6.1.5 Galderma Laboratories Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Company Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bausch Health Oral Retinoids Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Company Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Actavis Oral Retinoids Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Stiefel Laboratories
6.4.1 Stiefel Laboratories Company Information
6.4.2 Stiefel Laboratories Description and Business Overview
6.4.3 Stiefel Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stiefel Laboratories Oral Retinoids Product Portfolio
6.4.5 Stiefel Laboratories Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 GlaxoSmithKline Oral Retinoids Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Company Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 Barr Pharmaceuticals
6.7.1 Barr Pharmaceuticals Company Information
6.7.2 Barr Pharmaceuticals Description and Business Overview
6.7.3 Barr Pharmaceuticals Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
6.7.5 Barr Pharmaceuticals Recent Developments/Updates
6.8 Impax Laboratories
6.8.1 Impax Laboratories Company Information
6.8.2 Impax Laboratories Description and Business Overview
6.8.3 Impax Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Impax Laboratories Oral Retinoids Product Portfolio
6.8.5 Impax Laboratories Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Oral Retinoids Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Teva
6.10.1 Teva Company Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teva Oral Retinoids Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Alembic
6.11.1 Alembic Company Information
6.11.2 Alembic Description and Business Overview
6.11.3 Alembic Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Alembic Oral Retinoids Product Portfolio
6.11.5 Alembic Recent Developments/Updates
6.12 Sigmapharm Laboratories
6.12.1 Sigmapharm Laboratories Company Information
6.12.2 Sigmapharm Laboratories Description and Business Overview
6.12.3 Sigmapharm Laboratories Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
6.12.5 Sigmapharm Laboratories Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Upsher-Smith
6.14.1 Upsher-Smith Company Information
6.14.2 Upsher-Smith Description and Business Overview
6.14.3 Upsher-Smith Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Upsher-Smith Oral Retinoids Product Portfolio
6.14.5 Upsher-Smith Recent Developments/Updates
6.15 Zydus
6.15.1 Zydus Company Information
6.15.2 Zydus Description and Business Overview
6.15.3 Zydus Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zydus Oral Retinoids Product Portfolio
6.15.5 Zydus Recent Developments/Updates
6.16 Par Pharmaceutical
6.16.1 Par Pharmaceutical Company Information
6.16.2 Par Pharmaceutical Description and Business Overview
6.16.3 Par Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Par Pharmaceutical Oral Retinoids Product Portfolio
6.16.5 Par Pharmaceutical Recent Developments/Updates
6.17 Fuji Pharma
6.17.1 Fuji Pharma Company Information
6.17.2 Fuji Pharma Description and Business Overview
6.17.3 Fuji Pharma Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Fuji Pharma Oral Retinoids Product Portfolio
6.17.5 Fuji Pharma Recent Developments/Updates
6.18 Shandong Liangfu Pharmaceutical
6.18.1 Shandong Liangfu Pharmaceutical Company Information
6.18.2 Shandong Liangfu Pharmaceutical Description and Business Overview
6.18.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
6.18.5 Shandong Liangfu Pharmaceutical Recent Developments/Updates
6.19 Chongqing Huapont Pharmaceutical
6.19.1 Chongqing Huapont Pharmaceutical Company Information
6.19.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.19.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
6.19.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.20 Harbin Dazhong Pharmaceutical
6.20.1 Harbin Dazhong Pharmaceutical Company Information
6.20.2 Harbin Dazhong Pharmaceutical Description and Business Overview
6.20.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
6.20.5 Harbin Dazhong Pharmaceutical Recent Developments/Updates
6.21 Sichuan Med-Shine Pharmaceutical
6.21.1 Sichuan Med-Shine Pharmaceutical Company Information
6.21.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.21.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
6.21.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.22 Heilongjiang Fuhe Pharmaceutical
6.22.1 Heilongjiang Fuhe Pharmaceutical Company Information
6.22.2 Heilongjiang Fuhe Pharmaceutical Description and Business Overview
6.22.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
6.22.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
6.23 HEC Pharm
6.23.1 HEC Pharm Company Information
6.23.2 HEC Pharm Description and Business Overview
6.23.3 HEC Pharm Oral Retinoids Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 HEC Pharm Oral Retinoids Product Portfolio
6.23.5 HEC Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Retinoids Industry Chain Analysis
7.2 Oral Retinoids Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Retinoids Production Mode & Process Analysis
7.4 Oral Retinoids Sales and Marketing
7.4.1 Oral Retinoids Sales Channels
7.4.2 Oral Retinoids Distributors
7.5 Oral Retinoids Customer Analysis
8 Oral Retinoids Market Dynamics
8.1 Oral Retinoids Industry Trends
8.2 Oral Retinoids Market Drivers
8.3 Oral Retinoids Market Challenges
8.4 Oral Retinoids Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oral Retinoids Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Retinoids Market Value by Strength (US$ Million), 2025 vs 2032
Table 3. Global Oral Retinoids Market Value by Packaging (US$ Million), 2025 vs 2032
Table 4. Global Oral Retinoids Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Oral Retinoids Market Competitive Situation by Manufacturers in 2025
Table 6. Global Oral Retinoids Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Oral Retinoids Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Oral Retinoids Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Oral Retinoids Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Oral Retinoids Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Oral Retinoids, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Oral Retinoids, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Oral Retinoids, Product Types and Applications
Table 14. Global Key Manufacturers of Oral Retinoids, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Oral Retinoids Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Retinoids Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Oral Retinoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Oral Retinoids Sales by Region (K Units), 2021–2026
Table 20. Global Oral Retinoids Sales Market Share by Region (2021–2026)
Table 21. Global Oral Retinoids Sales by Region (K Units), 2027–2032
Table 22. Global Oral Retinoids Sales Market Share by Region (2027–2032)
Table 23. Global Oral Retinoids Revenue by Region (US$ Million), 2021–2026
Table 24. Global Oral Retinoids Revenue Market Share by Region (2021–2026)
Table 25. Global Oral Retinoids Revenue by Region (US$ Million), 2027–2032
Table 26. Global Oral Retinoids Revenue Market Share by Region (2027–2032)
Table 27. North America Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Oral Retinoids Sales by Country (K Units), 2021–2026
Table 29. North America Oral Retinoids Sales by Country (K Units), 2027–2032
Table 30. North America Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 31. North America Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Oral Retinoids Sales by Country (K Units), 2021–2026
Table 34. Europe Oral Retinoids Sales by Country (K Units), 2027–2032
Table 35. Europe Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Oral Retinoids Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Oral Retinoids Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Oral Retinoids Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Oral Retinoids Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Oral Retinoids Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Oral Retinoids Sales by Country (K Units), 2021–2026
Table 44. Latin America Oral Retinoids Sales by Country (K Units), 2027–2032
Table 45. Latin America Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Oral Retinoids Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Oral Retinoids Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 52. Global Oral Retinoids Sales (K Units) by Type (2021–2026)
Table 53. Global Oral Retinoids Sales (K Units) by Type (2027–2032)
Table 54. Global Oral Retinoids Sales Market Share by Type (2021–2026)
Table 55. Global Oral Retinoids Sales Market Share by Type (2027–2032)
Table 56. Global Oral Retinoids Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Oral Retinoids Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Oral Retinoids Revenue Market Share by Type (2021–2026)
Table 59. Global Oral Retinoids Revenue Market Share by Type (2027–2032)
Table 60. Global Oral Retinoids Price (US$/Unit) by Type (2021–2026)
Table 61. Global Oral Retinoids Price (US$/Unit) by Type (2027–2032)
Table 62. Global Oral Retinoids Sales (K Units) by Application (2021–2026)
Table 63. Global Oral Retinoids Sales (K Units) by Application (2027–2032)
Table 64. Global Oral Retinoids Sales Market Share by Application (2021–2026)
Table 65. Global Oral Retinoids Sales Market Share by Application (2027–2032)
Table 66. Global Oral Retinoids Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Oral Retinoids Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Oral Retinoids Revenue Market Share by Application (2021–2026)
Table 69. Global Oral Retinoids Revenue Market Share by Application (2027–2032)
Table 70. Global Oral Retinoids Price (US$/Unit) by Application (2021–2026)
Table 71. Global Oral Retinoids Price (US$/Unit) by Application (2027–2032)
Table 72. Galderma Laboratories Company Information
Table 73. Galderma Laboratories Description and Business Overview
Table 74. Galderma Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Galderma Laboratories Oral Retinoids Product
Table 76. Galderma Laboratories Recent Developments/Updates
Table 77. Bausch Health Company Information
Table 78. Bausch Health Description and Business Overview
Table 79. Bausch Health Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Bausch Health Oral Retinoids Product
Table 81. Bausch Health Recent Developments/Updates
Table 82. Actavis Company Information
Table 83. Actavis Description and Business Overview
Table 84. Actavis Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Actavis Oral Retinoids Product
Table 86. Actavis Recent Developments/Updates
Table 87. Stiefel Laboratories Company Information
Table 88. Stiefel Laboratories Description and Business Overview
Table 89. Stiefel Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Stiefel Laboratories Oral Retinoids Product
Table 91. Stiefel Laboratories Recent Developments/Updates
Table 92. GlaxoSmithKline Company Information
Table 93. GlaxoSmithKline Description and Business Overview
Table 94. GlaxoSmithKline Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. GlaxoSmithKline Oral Retinoids Product
Table 96. GlaxoSmithKline Recent Developments/Updates
Table 97. Dr. Reddy's Laboratories Company Information
Table 98. Dr. Reddy's Laboratories Description and Business Overview
Table 99. Dr. Reddy's Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Dr. Reddy's Laboratories Oral Retinoids Product
Table 101. Dr. Reddy's Laboratories Recent Developments/Updates
Table 102. Barr Pharmaceuticals Company Information
Table 103. Barr Pharmaceuticals Description and Business Overview
Table 104. Barr Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Barr Pharmaceuticals Oral Retinoids Product
Table 106. Barr Pharmaceuticals Recent Developments/Updates
Table 107. Impax Laboratories Company Information
Table 108. Impax Laboratories Description and Business Overview
Table 109. Impax Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Impax Laboratories Oral Retinoids Product
Table 111. Impax Laboratories Recent Developments/Updates
Table 112. Mylan Company Information
Table 113. Mylan Description and Business Overview
Table 114. Mylan Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Mylan Oral Retinoids Product
Table 116. Mylan Recent Developments/Updates
Table 117. Teva Company Information
Table 118. Teva Description and Business Overview
Table 119. Teva Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Teva Oral Retinoids Product
Table 121. Teva Recent Developments/Updates
Table 122. Alembic Company Information
Table 123. Alembic Description and Business Overview
Table 124. Alembic Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Alembic Oral Retinoids Product
Table 126. Alembic Recent Developments/Updates
Table 127. Sigmapharm Laboratories Company Information
Table 128. Sigmapharm Laboratories Description and Business Overview
Table 129. Sigmapharm Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Sigmapharm Laboratories Oral Retinoids Product
Table 131. Sigmapharm Laboratories Recent Developments/Updates
Table 132. Amneal Pharmaceuticals Company Information
Table 133. Amneal Pharmaceuticals Description and Business Overview
Table 134. Amneal Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Amneal Pharmaceuticals Oral Retinoids Product
Table 136. Amneal Pharmaceuticals Recent Developments/Updates
Table 137. Upsher-Smith Company Information
Table 138. Upsher-Smith Description and Business Overview
Table 139. Upsher-Smith Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Upsher-Smith Oral Retinoids Product
Table 141. Upsher-Smith Recent Developments/Updates
Table 142. Zydus Company Information
Table 143. Zydus Description and Business Overview
Table 144. Zydus Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Zydus Oral Retinoids Product
Table 146. Zydus Recent Developments/Updates
Table 147. Par Pharmaceutical Company Information
Table 148. Par Pharmaceutical Description and Business Overview
Table 149. Par Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Par Pharmaceutical Oral Retinoids Product
Table 151. Par Pharmaceutical Recent Developments/Updates
Table 152. Fuji Pharma Company Information
Table 153. Fuji Pharma Description and Business Overview
Table 154. Fuji Pharma Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. Fuji Pharma Oral Retinoids Product
Table 156. Fuji Pharma Recent Developments/Updates
Table 157. Shandong Liangfu Pharmaceutical Company Information
Table 158. Shandong Liangfu Pharmaceutical Description and Business Overview
Table 159. Shandong Liangfu Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Shandong Liangfu Pharmaceutical Oral Retinoids Product
Table 161. Shandong Liangfu Pharmaceutical Recent Developments/Updates
Table 162. Chongqing Huapont Pharmaceutical Company Information
Table 163. Chongqing Huapont Pharmaceutical Description and Business Overview
Table 164. Chongqing Huapont Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. Chongqing Huapont Pharmaceutical Oral Retinoids Product
Table 166. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 167. Harbin Dazhong Pharmaceutical Company Information
Table 168. Harbin Dazhong Pharmaceutical Description and Business Overview
Table 169. Harbin Dazhong Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Harbin Dazhong Pharmaceutical Oral Retinoids Product
Table 171. Harbin Dazhong Pharmaceutical Recent Developments/Updates
Table 172. Sichuan Med-Shine Pharmaceutical Company Information
Table 173. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 174. Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. Sichuan Med-Shine Pharmaceutical Oral Retinoids Product
Table 176. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 177. Heilongjiang Fuhe Pharmaceutical Company Information
Table 178. Heilongjiang Fuhe Pharmaceutical Description and Business Overview
Table 179. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product
Table 181. Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
Table 182. HEC Pharm Company Information
Table 183. HEC Pharm Description and Business Overview
Table 184. HEC Pharm Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. HEC Pharm Oral Retinoids Product
Table 186. HEC Pharm Recent Developments/Updates
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Oral Retinoids Distributors List
Table 190. Oral Retinoids Customers List
Table 191. Oral Retinoids Market Trends
Table 192. Oral Retinoids Market Drivers
Table 193. Oral Retinoids Market Challenges
Table 194. Oral Retinoids Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
Table 198. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Retinoids
Figure 2. Global Oral Retinoids Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Retinoids Market Share by Type: 2025 & 2032
Figure 4. Tretinoin Product Picture
Figure 5. Isotretinoin Product Picture
Figure 6. Acitretin Product Picture
Figure 7. Bexarotene Product Picture
Figure 8. Alitretinoin Product Picture
Figure 9. Global Oral Retinoids Market Value by Strength (US$ Million), 2021–2032
Figure 10. Global Oral Retinoids Market Share by Strength: 2025 vs 2032
Figure 11. Low Strength Product Picture
Figure 12. Medium Strength Product Picture
Figure 13. High Strength Product Picture
Figure 14. Global Oral Retinoids Market Value by Packaging (US$ Million), 2021–2032
Figure 15. Global Oral Retinoids Market Share by Packaging: 2025 vs 2032
Figure 16. Bottle Pack Product Picture
Figure 17. Blister Pack Product Picture
Figure 18. Global Oral Retinoids Market Value by Application (US$ Million), 2021–2032
Figure 19. Global Oral Retinoids Market Share by Application: 2025 & 2032
Figure 20. Hospital and Clinic
Figure 21. Pharmacy
Figure 22. Other
Figure 23. Global Oral Retinoids Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Oral Retinoids Market Size (US$ Million), 2021–2032
Figure 25. Global Oral Retinoids Sales (K Units), 2021–2032
Figure 26. Global Oral Retinoids Average Price (US$/Unit), 2021–2032
Figure 27. Oral Retinoids Report Years Considered
Figure 28. Oral Retinoids Sales Share by Manufacturers in 2025
Figure 29. Global Oral Retinoids Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Oral Retinoids Players: Market Share by Revenue in Oral Retinoids in 2025
Figure 31. Oral Retinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Oral Retinoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 34. North America Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 35. United States Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 38. Europe Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 39. Germany Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Oral Retinoids Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Oral Retinoids Revenue Market Share by Region (2021–2032)
Figure 46. China Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 54. Latin America Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Colombia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. UAE Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Oral Retinoids by Type (2021–2032)
Figure 65. Global Revenue Market Share of Oral Retinoids by Type (2021–2032)
Figure 66. Global Oral Retinoids Price (US$/Unit) by Type (2021–2032)
Figure 67. Global Sales Market Share of Oral Retinoids by Application (2021–2032)
Figure 68. Global Revenue Market Share of Oral Retinoids by Application (2021–2032)
Figure 69. Global Oral Retinoids Price (US$/Unit) by Application (2021–2032)
Figure 70. Oral Retinoids Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Oral Retinoids Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Retinoids Market Value by Strength (US$ Million), 2025 vs 2032
Table 3. Global Oral Retinoids Market Value by Packaging (US$ Million), 2025 vs 2032
Table 4. Global Oral Retinoids Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Oral Retinoids Market Competitive Situation by Manufacturers in 2025
Table 6. Global Oral Retinoids Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Oral Retinoids Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Oral Retinoids Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Oral Retinoids Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Oral Retinoids Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Oral Retinoids, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Oral Retinoids, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Oral Retinoids, Product Types and Applications
Table 14. Global Key Manufacturers of Oral Retinoids, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Oral Retinoids Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Retinoids Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Oral Retinoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Oral Retinoids Sales by Region (K Units), 2021–2026
Table 20. Global Oral Retinoids Sales Market Share by Region (2021–2026)
Table 21. Global Oral Retinoids Sales by Region (K Units), 2027–2032
Table 22. Global Oral Retinoids Sales Market Share by Region (2027–2032)
Table 23. Global Oral Retinoids Revenue by Region (US$ Million), 2021–2026
Table 24. Global Oral Retinoids Revenue Market Share by Region (2021–2026)
Table 25. Global Oral Retinoids Revenue by Region (US$ Million), 2027–2032
Table 26. Global Oral Retinoids Revenue Market Share by Region (2027–2032)
Table 27. North America Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Oral Retinoids Sales by Country (K Units), 2021–2026
Table 29. North America Oral Retinoids Sales by Country (K Units), 2027–2032
Table 30. North America Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 31. North America Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Oral Retinoids Sales by Country (K Units), 2021–2026
Table 34. Europe Oral Retinoids Sales by Country (K Units), 2027–2032
Table 35. Europe Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Oral Retinoids Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Oral Retinoids Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Oral Retinoids Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Oral Retinoids Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Oral Retinoids Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Oral Retinoids Sales by Country (K Units), 2021–2026
Table 44. Latin America Oral Retinoids Sales by Country (K Units), 2027–2032
Table 45. Latin America Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Oral Retinoids Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Oral Retinoids Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Oral Retinoids Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Oral Retinoids Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Oral Retinoids Revenue by Country (US$ Million), 2027–2032
Table 52. Global Oral Retinoids Sales (K Units) by Type (2021–2026)
Table 53. Global Oral Retinoids Sales (K Units) by Type (2027–2032)
Table 54. Global Oral Retinoids Sales Market Share by Type (2021–2026)
Table 55. Global Oral Retinoids Sales Market Share by Type (2027–2032)
Table 56. Global Oral Retinoids Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Oral Retinoids Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Oral Retinoids Revenue Market Share by Type (2021–2026)
Table 59. Global Oral Retinoids Revenue Market Share by Type (2027–2032)
Table 60. Global Oral Retinoids Price (US$/Unit) by Type (2021–2026)
Table 61. Global Oral Retinoids Price (US$/Unit) by Type (2027–2032)
Table 62. Global Oral Retinoids Sales (K Units) by Application (2021–2026)
Table 63. Global Oral Retinoids Sales (K Units) by Application (2027–2032)
Table 64. Global Oral Retinoids Sales Market Share by Application (2021–2026)
Table 65. Global Oral Retinoids Sales Market Share by Application (2027–2032)
Table 66. Global Oral Retinoids Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Oral Retinoids Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Oral Retinoids Revenue Market Share by Application (2021–2026)
Table 69. Global Oral Retinoids Revenue Market Share by Application (2027–2032)
Table 70. Global Oral Retinoids Price (US$/Unit) by Application (2021–2026)
Table 71. Global Oral Retinoids Price (US$/Unit) by Application (2027–2032)
Table 72. Galderma Laboratories Company Information
Table 73. Galderma Laboratories Description and Business Overview
Table 74. Galderma Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Galderma Laboratories Oral Retinoids Product
Table 76. Galderma Laboratories Recent Developments/Updates
Table 77. Bausch Health Company Information
Table 78. Bausch Health Description and Business Overview
Table 79. Bausch Health Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Bausch Health Oral Retinoids Product
Table 81. Bausch Health Recent Developments/Updates
Table 82. Actavis Company Information
Table 83. Actavis Description and Business Overview
Table 84. Actavis Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Actavis Oral Retinoids Product
Table 86. Actavis Recent Developments/Updates
Table 87. Stiefel Laboratories Company Information
Table 88. Stiefel Laboratories Description and Business Overview
Table 89. Stiefel Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Stiefel Laboratories Oral Retinoids Product
Table 91. Stiefel Laboratories Recent Developments/Updates
Table 92. GlaxoSmithKline Company Information
Table 93. GlaxoSmithKline Description and Business Overview
Table 94. GlaxoSmithKline Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. GlaxoSmithKline Oral Retinoids Product
Table 96. GlaxoSmithKline Recent Developments/Updates
Table 97. Dr. Reddy's Laboratories Company Information
Table 98. Dr. Reddy's Laboratories Description and Business Overview
Table 99. Dr. Reddy's Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Dr. Reddy's Laboratories Oral Retinoids Product
Table 101. Dr. Reddy's Laboratories Recent Developments/Updates
Table 102. Barr Pharmaceuticals Company Information
Table 103. Barr Pharmaceuticals Description and Business Overview
Table 104. Barr Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Barr Pharmaceuticals Oral Retinoids Product
Table 106. Barr Pharmaceuticals Recent Developments/Updates
Table 107. Impax Laboratories Company Information
Table 108. Impax Laboratories Description and Business Overview
Table 109. Impax Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Impax Laboratories Oral Retinoids Product
Table 111. Impax Laboratories Recent Developments/Updates
Table 112. Mylan Company Information
Table 113. Mylan Description and Business Overview
Table 114. Mylan Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Mylan Oral Retinoids Product
Table 116. Mylan Recent Developments/Updates
Table 117. Teva Company Information
Table 118. Teva Description and Business Overview
Table 119. Teva Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Teva Oral Retinoids Product
Table 121. Teva Recent Developments/Updates
Table 122. Alembic Company Information
Table 123. Alembic Description and Business Overview
Table 124. Alembic Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Alembic Oral Retinoids Product
Table 126. Alembic Recent Developments/Updates
Table 127. Sigmapharm Laboratories Company Information
Table 128. Sigmapharm Laboratories Description and Business Overview
Table 129. Sigmapharm Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Sigmapharm Laboratories Oral Retinoids Product
Table 131. Sigmapharm Laboratories Recent Developments/Updates
Table 132. Amneal Pharmaceuticals Company Information
Table 133. Amneal Pharmaceuticals Description and Business Overview
Table 134. Amneal Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Amneal Pharmaceuticals Oral Retinoids Product
Table 136. Amneal Pharmaceuticals Recent Developments/Updates
Table 137. Upsher-Smith Company Information
Table 138. Upsher-Smith Description and Business Overview
Table 139. Upsher-Smith Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Upsher-Smith Oral Retinoids Product
Table 141. Upsher-Smith Recent Developments/Updates
Table 142. Zydus Company Information
Table 143. Zydus Description and Business Overview
Table 144. Zydus Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Zydus Oral Retinoids Product
Table 146. Zydus Recent Developments/Updates
Table 147. Par Pharmaceutical Company Information
Table 148. Par Pharmaceutical Description and Business Overview
Table 149. Par Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Par Pharmaceutical Oral Retinoids Product
Table 151. Par Pharmaceutical Recent Developments/Updates
Table 152. Fuji Pharma Company Information
Table 153. Fuji Pharma Description and Business Overview
Table 154. Fuji Pharma Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. Fuji Pharma Oral Retinoids Product
Table 156. Fuji Pharma Recent Developments/Updates
Table 157. Shandong Liangfu Pharmaceutical Company Information
Table 158. Shandong Liangfu Pharmaceutical Description and Business Overview
Table 159. Shandong Liangfu Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Shandong Liangfu Pharmaceutical Oral Retinoids Product
Table 161. Shandong Liangfu Pharmaceutical Recent Developments/Updates
Table 162. Chongqing Huapont Pharmaceutical Company Information
Table 163. Chongqing Huapont Pharmaceutical Description and Business Overview
Table 164. Chongqing Huapont Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. Chongqing Huapont Pharmaceutical Oral Retinoids Product
Table 166. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 167. Harbin Dazhong Pharmaceutical Company Information
Table 168. Harbin Dazhong Pharmaceutical Description and Business Overview
Table 169. Harbin Dazhong Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Harbin Dazhong Pharmaceutical Oral Retinoids Product
Table 171. Harbin Dazhong Pharmaceutical Recent Developments/Updates
Table 172. Sichuan Med-Shine Pharmaceutical Company Information
Table 173. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 174. Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. Sichuan Med-Shine Pharmaceutical Oral Retinoids Product
Table 176. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 177. Heilongjiang Fuhe Pharmaceutical Company Information
Table 178. Heilongjiang Fuhe Pharmaceutical Description and Business Overview
Table 179. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product
Table 181. Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
Table 182. HEC Pharm Company Information
Table 183. HEC Pharm Description and Business Overview
Table 184. HEC Pharm Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. HEC Pharm Oral Retinoids Product
Table 186. HEC Pharm Recent Developments/Updates
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Oral Retinoids Distributors List
Table 190. Oral Retinoids Customers List
Table 191. Oral Retinoids Market Trends
Table 192. Oral Retinoids Market Drivers
Table 193. Oral Retinoids Market Challenges
Table 194. Oral Retinoids Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
Table 198. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Retinoids
Figure 2. Global Oral Retinoids Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Retinoids Market Share by Type: 2025 & 2032
Figure 4. Tretinoin Product Picture
Figure 5. Isotretinoin Product Picture
Figure 6. Acitretin Product Picture
Figure 7. Bexarotene Product Picture
Figure 8. Alitretinoin Product Picture
Figure 9. Global Oral Retinoids Market Value by Strength (US$ Million), 2021–2032
Figure 10. Global Oral Retinoids Market Share by Strength: 2025 vs 2032
Figure 11. Low Strength Product Picture
Figure 12. Medium Strength Product Picture
Figure 13. High Strength Product Picture
Figure 14. Global Oral Retinoids Market Value by Packaging (US$ Million), 2021–2032
Figure 15. Global Oral Retinoids Market Share by Packaging: 2025 vs 2032
Figure 16. Bottle Pack Product Picture
Figure 17. Blister Pack Product Picture
Figure 18. Global Oral Retinoids Market Value by Application (US$ Million), 2021–2032
Figure 19. Global Oral Retinoids Market Share by Application: 2025 & 2032
Figure 20. Hospital and Clinic
Figure 21. Pharmacy
Figure 22. Other
Figure 23. Global Oral Retinoids Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Oral Retinoids Market Size (US$ Million), 2021–2032
Figure 25. Global Oral Retinoids Sales (K Units), 2021–2032
Figure 26. Global Oral Retinoids Average Price (US$/Unit), 2021–2032
Figure 27. Oral Retinoids Report Years Considered
Figure 28. Oral Retinoids Sales Share by Manufacturers in 2025
Figure 29. Global Oral Retinoids Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Oral Retinoids Players: Market Share by Revenue in Oral Retinoids in 2025
Figure 31. Oral Retinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Oral Retinoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 34. North America Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 35. United States Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 38. Europe Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 39. Germany Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Oral Retinoids Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Oral Retinoids Revenue Market Share by Region (2021–2032)
Figure 46. China Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 54. Latin America Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Colombia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Oral Retinoids Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Oral Retinoids Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. UAE Oral Retinoids Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Oral Retinoids by Type (2021–2032)
Figure 65. Global Revenue Market Share of Oral Retinoids by Type (2021–2032)
Figure 66. Global Oral Retinoids Price (US$/Unit) by Type (2021–2032)
Figure 67. Global Sales Market Share of Oral Retinoids by Application (2021–2032)
Figure 68. Global Revenue Market Share of Oral Retinoids by Application (2021–2032)
Figure 69. Global Oral Retinoids Price (US$/Unit) by Application (2021–2032)
Figure 70. Oral Retinoids Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232